Objective: To evaluate the reliability and validity of the Italian brief-QOD (Brief-IT-QOD). Methods: The study consisted of six phases: item generation, reliability analysis (112 dysosmic patients for internal consistency analysis and 61 for test-retest reliability analysis), normative data generation (303 normosmic subjects), validity analysis (comparison of Brief-IT-QOD scores of healthy and dysosmic subjects and scores correlation with psychophysical olfactory testing (TDI) and SNOT-22 scores), responsiveness analysis (10 dysosmic chronic rhinosinusitis with nasal polyps (CRSwNP) patients before and after biologic therapy), and cut-off value determination (ROC curve analysis of Brief-IT-QOD sensitivity and specificity). Results: All subjects completed the Brief-IT-QOD. Internal consistency (α > 0.70) and test-retest reliability (ICC > 0.7) were acceptable and satisfactory for both questionnaire subscales. A significant difference between dysosmic and control subjects was found in both subscales (p < 0.05). Significant correlations between subscales scores and TDI and SNOT-22 scores were observed. Brief-IT-QOD scores before treatment were significantly higher than after biological therapy. Conclusions: Brief-IT-QOD is reliable, valid, responsive to changes in QoL, and recommended for clinical practice and outcome research.
Italian version of the brief Questionnaire of Olfactory Disorders (brief-IT-QOD) / A. Cardella, G. Riva, A. Preti, A. Albera, L. Luzi, R. Albera, D. Cadei, G.M. Motatto, F. Omenetti, G. Pecorari, F. Ottaviani, F. Mozzanica. - In: ACTA OTORHINOLARYNGOLOGICA ITALICA. - ISSN 1827-675X. - (2023), pp. 1-10. [Epub ahead of print] [10.14639/0392-100X-N2212]
Italian version of the brief Questionnaire of Olfactory Disorders (brief-IT-QOD)
A. Cardella
Primo
;L. Luzi;D. Cadei;F. Omenetti;F. Ottaviani;F. MozzanicaUltimo
2023
Abstract
Objective: To evaluate the reliability and validity of the Italian brief-QOD (Brief-IT-QOD). Methods: The study consisted of six phases: item generation, reliability analysis (112 dysosmic patients for internal consistency analysis and 61 for test-retest reliability analysis), normative data generation (303 normosmic subjects), validity analysis (comparison of Brief-IT-QOD scores of healthy and dysosmic subjects and scores correlation with psychophysical olfactory testing (TDI) and SNOT-22 scores), responsiveness analysis (10 dysosmic chronic rhinosinusitis with nasal polyps (CRSwNP) patients before and after biologic therapy), and cut-off value determination (ROC curve analysis of Brief-IT-QOD sensitivity and specificity). Results: All subjects completed the Brief-IT-QOD. Internal consistency (α > 0.70) and test-retest reliability (ICC > 0.7) were acceptable and satisfactory for both questionnaire subscales. A significant difference between dysosmic and control subjects was found in both subscales (p < 0.05). Significant correlations between subscales scores and TDI and SNOT-22 scores were observed. Brief-IT-QOD scores before treatment were significantly higher than after biological therapy. Conclusions: Brief-IT-QOD is reliable, valid, responsive to changes in QoL, and recommended for clinical practice and outcome research.File | Dimensione | Formato | |
---|---|---|---|
2212-Article Text-24648-1-10-20230523.pdf
accesso aperto
Descrizione: online first
Tipologia:
Publisher's version/PDF
Dimensione
205.22 kB
Formato
Adobe PDF
|
205.22 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.